DK1141306T3 - Streptococcus-antigener - Google Patents

Streptococcus-antigener

Info

Publication number
DK1141306T3
DK1141306T3 DK99960748T DK99960748T DK1141306T3 DK 1141306 T3 DK1141306 T3 DK 1141306T3 DK 99960748 T DK99960748 T DK 99960748T DK 99960748 T DK99960748 T DK 99960748T DK 1141306 T3 DK1141306 T3 DK 1141306T3
Authority
DK
Denmark
Prior art keywords
streptococcal antigens
streptococcal
antigens
Prior art date
Application number
DK99960748T
Other languages
Danish (da)
English (en)
Inventor
Josee Hamel
Bernard R Brodeur
Isabelle Pineau
Denis Martin
Clement Rioux
Nathalie Charland
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22351610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1141306(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Application granted granted Critical
Publication of DK1141306T3 publication Critical patent/DK1141306T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK99960748T 1998-12-23 1999-12-20 Streptococcus-antigener DK1141306T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11380098P 1998-12-23 1998-12-23
PCT/CA1999/001218 WO2000039299A2 (fr) 1998-12-23 1999-12-20 Antigenes de streptococcus

Publications (1)

Publication Number Publication Date
DK1141306T3 true DK1141306T3 (da) 2008-08-18

Family

ID=22351610

Family Applications (3)

Application Number Title Priority Date Filing Date
DK99960748T DK1141306T3 (da) 1998-12-23 1999-12-20 Streptococcus-antigener
DK08155317.4T DK1950302T3 (da) 1998-12-23 1999-12-20 Streptokok-antigener.
DK10180372.4T DK2261358T3 (da) 1998-12-23 1999-12-20 Nyt streptococcus-antigen

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK08155317.4T DK1950302T3 (da) 1998-12-23 1999-12-20 Streptokok-antigener.
DK10180372.4T DK2261358T3 (da) 1998-12-23 1999-12-20 Nyt streptococcus-antigen

Country Status (30)

Country Link
EP (2) EP2261358B1 (fr)
JP (2) JP4761623B2 (fr)
KR (4) KR101078919B1 (fr)
CN (3) CN1191362C (fr)
AP (1) AP2001002199A0 (fr)
AR (1) AR029322A1 (fr)
AT (1) ATE394489T1 (fr)
AU (1) AU1764900A (fr)
BR (1) BR9916477A (fr)
CA (1) CA2356836C (fr)
CL (1) CL2009002037A1 (fr)
CY (3) CY1108223T1 (fr)
CZ (2) CZ302790B6 (fr)
DE (1) DE69938670D1 (fr)
DK (3) DK1141306T3 (fr)
EA (1) EA007409B1 (fr)
ES (3) ES2306528T3 (fr)
HK (1) HK1118575A1 (fr)
HU (1) HU229664B1 (fr)
IL (3) IL143905A0 (fr)
MX (1) MXPA01006427A (fr)
NO (1) NO330800B1 (fr)
NZ (1) NZ512574A (fr)
OA (1) OA11736A (fr)
PL (3) PL205041B1 (fr)
PT (3) PT1141306E (fr)
TR (2) TR200102497T2 (fr)
UY (1) UY25877A1 (fr)
WO (1) WO2000039299A2 (fr)
ZA (1) ZA200105114B (fr)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1944652A (zh) 1998-02-20 2007-04-11 益德生物医药公司 B组链球菌抗原
EP1801218A3 (fr) * 1998-07-27 2007-10-10 Sanofi Pasteur Limited Acides nucléiques et protéines de la pneumonie à streptocoques
US20030134407A1 (en) 1998-07-27 2003-07-17 Le Page Richard William Falla Nucleic acids and proteins from Streptococcus pneumoniae
WO2000037105A2 (fr) 1998-12-21 2000-06-29 Medimmune, Inc. Proteines de streptococcus pneumoniae et fragments immunogenes pour vaccins
DE69938670D1 (de) * 1998-12-23 2008-06-19 Id Biomedical Corp Streptococcus antigene
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
PT1294771E (pt) 2000-06-12 2009-01-06 Univ Saskatchewan Proteína gapc quimérica de streptococcus e sua utilização em vacinação e diagnóstico
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
WO2001098334A2 (fr) 2000-06-20 2001-12-27 Shire Biochem Inc. Antigenes de streptocoque
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
WO2002079475A2 (fr) * 2001-03-30 2002-10-10 Shire Biochem Inc. Antigenes streptococcus pyogenes et fragments d'adn correspondants
BR0210875A (pt) * 2001-07-06 2004-06-22 Shire Biochem Inc Antìgenos de streptococcus do grupo b e fragmentos de dna correspondentes
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
US7262024B2 (en) 2001-12-20 2007-08-28 Id Biomedical Corporation Streptococcus antigens
CN1756843B (zh) 2003-03-04 2012-03-21 英特塞尔股份公司 化脓链球菌抗原
AU2004230244B2 (en) 2003-04-15 2011-09-22 Intercell Ag S. pneumoniae antigens
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
NO346529B1 (no) 2005-12-22 2022-09-26 Glaxosmithkline Biologicals Sa Bruk av et immunogenpreparat for småbarn, omfattende 22F sakkaridkonjugat
CN101883583B (zh) 2007-06-26 2017-05-17 葛兰素史密丝克莱恩生物有限公司 含有肺炎链球菌荚膜多糖缀合物的疫苗
AU2008280799B2 (en) * 2007-07-23 2013-07-11 Sanofi Pasteur Limited Immunogenic polypeptides and monoclonal antibodies
WO2009127676A1 (fr) * 2008-04-16 2009-10-22 Glaxosmithkline Biologicals S.A. Vaccin
CA2738245A1 (fr) 2008-09-26 2010-04-01 Nanobio Corporation Compositions therapeutiques de nanoemulsion et procedes d'utilisation de celles-ci
CA2757620C (fr) 2009-04-30 2016-04-26 Coley Pharmaceutical Group, Inc. Vaccin anti-pneumococcique et ses utilisations
US8668911B2 (en) 2009-05-14 2014-03-11 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
CN104548089B (zh) 2009-09-03 2017-09-26 辉瑞疫苗有限责任公司 Pcsk9疫苗
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
EP2646049B1 (fr) 2010-12-03 2018-05-02 Sanofi Pasteur Limited Composition pour l'immunisation contre streptococcus pneumoniae
MY163871A (en) * 2011-01-20 2017-10-31 Genocea Biosciences Inc Vaccines and compositions against streptococcus pneumoniae
EP2680883B1 (fr) 2011-03-02 2018-09-05 Pfizer Inc Vaccin à base de pcsk9
EA201391456A1 (ru) 2011-05-17 2014-05-30 Глаксосмитклайн Байолоджикалс С.А. ВАКЦИНА ПРОТИВ Streptococcus pneumoniae
CN105142662B (zh) * 2012-01-05 2017-07-07 德国癌症研究中心 Idh1 r132h突变阳性癌症治疗或诊断的手段与方法
WO2014089706A1 (fr) * 2012-12-14 2014-06-19 Sanofi Pasteur, Ltd. Méthodes pour évaluer l'immunogénicité
NZ759686A (en) 2014-01-21 2023-07-28 Pfizer Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
HRP20231504T1 (hr) 2014-01-21 2024-03-01 Pfizer Inc. Polisaharidi kapsule iz bakterije streptococcus pneumoniae i njihovi konjugati
US11160855B2 (en) 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN105934251A (zh) 2014-01-21 2016-09-07 辉瑞大药厂 肺炎链球菌荚膜多糖及其缀合物
JP2017505792A (ja) 2014-02-14 2017-02-23 ファイザー・インク 免疫原性糖タンパク質コンジュゲート
HUE062499T2 (hu) 2015-01-15 2023-11-28 Pfizer Pneumococcus-vakcinákban történõ alkalmazásra szolgáló immunogén készítmények
RU2721128C2 (ru) 2015-07-21 2020-05-18 Пфайзер Инк. Иммуногенные композиции, содержащие конъюгированные антигены капсульного сахарида, наборы, содержащие эти композиции, и их применения
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
WO2017085586A1 (fr) 2015-11-20 2017-05-26 Pfizer Inc. Compositions immunogènes destinées à être utilisées dans des vaccins pneumococciques
GB201610599D0 (en) 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition
RU2762723C2 (ru) 2017-01-20 2021-12-22 Пфайзер Инк. Иммуногенные композиции для применения в пневмококковых вакцинах
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
EP3893926A1 (fr) 2018-12-12 2021-10-20 Pfizer Inc. Conjugués polysaccharide-protéine immunogènes à hétéroantigènes multiples et leurs utilisations
JP7239509B6 (ja) 2019-02-22 2023-03-28 ファイザー・インク 細菌多糖類を精製するための方法
WO2020208502A1 (fr) 2019-04-10 2020-10-15 Pfizer Inc. Compositions immunogènes comprenant des antigènes saccharidiques capsulaires conjugués, kits les comprenant et leurs utilisations
EP4003410A1 (fr) 2019-07-31 2022-06-01 Sanofi Pasteur, Inc. Compositions de conjugués de polysaccharide-protéine pneumococcique multivalents leurs méthodes d'utilisation
CN114667343A (zh) 2019-11-01 2022-06-24 辉瑞大药厂 大肠杆菌组合物及其方法
US20230085173A1 (en) 2020-02-21 2023-03-16 Pfizer Inc. Purification of saccharides
BR112022014555A2 (pt) 2020-02-23 2022-09-20 Pfizer Composições de escherichia coli e métodos das mesmas.
JP2023546446A (ja) 2020-10-22 2023-11-02 ファイザー・インク 細菌多糖を精製する方法
AU2021368151A1 (en) 2020-10-27 2023-06-01 Pfizer Inc. Escherichia coli compositions and methods thereof
CN116744965A (zh) 2020-11-04 2023-09-12 辉瑞大药厂 用于肺炎球菌疫苗的免疫原性组合物
US20220202923A1 (en) 2020-12-23 2022-06-30 Pfizer Inc. E. coli fimh mutants and uses thereof
JP2024517780A (ja) 2021-05-03 2024-04-23 ファイザー・インク 細菌およびベータコロナウイルス感染症に対するワクチン接種
WO2022234416A1 (fr) 2021-05-03 2022-11-10 Pfizer Inc. Vaccination contre des infections à pneumocoque et à covid-19
BR112023023671A2 (pt) 2021-05-28 2024-02-06 Pfizer Composições imunogênicas compreendendo antígenos de sacarídeo capsular conjugados e usos dos mesmos
US20220387576A1 (en) 2021-05-28 2022-12-08 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2023135515A1 (fr) 2022-01-13 2023-07-20 Pfizer Inc. Compositions immunogènes à base d'antigènes saccharidiques capsulaires conjugués et leurs utilisations
WO2023161817A1 (fr) 2022-02-25 2023-08-31 Pfizer Inc. Procédés d'incorporation de groupes azido dans des polysaccharides capsulaires bactériens
WO2023218322A1 (fr) 2022-05-11 2023-11-16 Pfizer Inc. Procédé de production de formulations de vaccin avec des conservateurs
WO2024084397A1 (fr) 2022-10-19 2024-04-25 Pfizer Inc. Vaccination contre infections à pneumocoques et à covid-19

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
SG47049A1 (en) * 1993-03-19 1998-03-20 Gunnar Lindahl Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit
CZ394297A3 (cs) * 1995-06-07 1998-04-15 Biochem Vaccines Inc. Streptokokové proteiny teplotního šoku ze skupiny HSP70
US5882896A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation M protein
US5928895A (en) * 1996-09-24 1999-07-27 Smithkline Beecham Corporation IgA Fc binding protein
AU5194598A (en) * 1996-10-31 1998-05-22 Human Genome Sciences, Inc. (streptococcus pneumoniae) antigens and vaccines
CN1291233A (zh) * 1997-09-24 2001-04-11 美国明尼苏达州大学 来自肺炎链球菌之人类补体c3降解蛋白酶
JP2002516251A (ja) * 1998-04-23 2002-06-04 ユーエイビー リサーチ ファンデーション 肺炎球菌表面プロテインＣ（ＰｓｐＣ）のエピトープ領域およびその菌株選択、ならびにそのための使用法
EP1144640A3 (fr) * 1998-07-27 2001-11-28 Microbial Technics Limited Acides nucleiques et proteines de streptococcus pneumoniae
EP2053126A1 (fr) * 1998-07-27 2009-04-29 Sanofi Pasteur Limited Protéines de pneumonie à streptocoques et molécules d'acide nucléique
BR9914066A (pt) * 1998-09-24 2002-04-23 Univ Minnesota Polipeptìdio degradador de c3 de complemento humano de streptococcus pneumoniae
WO2000037105A2 (fr) * 1998-12-21 2000-06-29 Medimmune, Inc. Proteines de streptococcus pneumoniae et fragments immunogenes pour vaccins
DE69938670D1 (de) * 1998-12-23 2008-06-19 Id Biomedical Corp Streptococcus antigene

Also Published As

Publication number Publication date
HK1118575A1 (en) 2009-02-13
IL143905A (en) 2011-05-31
IL143905A0 (en) 2002-04-21
NO20013045L (no) 2001-08-20
KR101078919B1 (ko) 2011-11-01
EP1141306A2 (fr) 2001-10-10
EP1141306B1 (fr) 2008-05-07
TR200200633T2 (tr) 2002-06-21
DK2261358T3 (da) 2014-07-28
IL194230A0 (en) 2011-08-01
CA2356836A1 (fr) 2000-07-06
CY1115340T1 (el) 2017-01-04
EP2261358A2 (fr) 2010-12-15
IL194230A (en) 2013-12-31
KR100891398B1 (ko) 2009-04-02
JP2010142246A (ja) 2010-07-01
CA2356836C (fr) 2011-09-13
EP2261358B1 (fr) 2014-05-14
KR20010104693A (ko) 2001-11-26
HUP0104774A2 (hu) 2002-04-29
ES2400280T3 (es) 2013-04-08
OA11736A (en) 2005-06-12
CN1191362C (zh) 2005-03-02
KR20100063814A (ko) 2010-06-11
CN1332803A (zh) 2002-01-23
KR100802198B1 (ko) 2008-02-11
HUP0104774A3 (en) 2007-10-29
PL204073B1 (pl) 2009-12-31
EP2261358A3 (fr) 2011-02-23
AU1764900A (en) 2000-07-31
AP2001002199A0 (en) 2001-09-30
JP2002533123A (ja) 2002-10-08
DE69938670D1 (de) 2008-06-19
PT1141306E (pt) 2008-07-30
PT2261358E (pt) 2014-07-30
ES2306528T3 (es) 2008-11-01
PL205041B1 (pl) 2010-03-31
EA007409B1 (ru) 2006-10-27
MXPA01006427A (es) 2002-06-04
JP4761623B2 (ja) 2011-08-31
CY1108223T1 (el) 2014-02-12
KR20080036666A (ko) 2008-04-28
BR9916477A (pt) 2004-06-22
JP5039802B2 (ja) 2012-10-03
PL206576B1 (pl) 2010-08-31
NO330800B1 (no) 2011-07-18
DK1950302T3 (da) 2013-01-14
CZ20012161A3 (cs) 2001-10-17
UY25877A1 (es) 2000-08-21
TR200102497T2 (tr) 2002-01-21
ES2480417T3 (es) 2014-07-28
CY1114722T1 (el) 2016-10-05
CN100398653C (zh) 2008-07-02
KR20060134227A (ko) 2006-12-27
NO20013045D0 (no) 2001-06-19
EA200100565A1 (ru) 2002-04-25
CL2009002037A1 (es) 2010-06-25
HU229664B1 (en) 2014-04-28
CZ303675B6 (cs) 2013-02-27
PT1950302E (pt) 2013-01-16
CZ302790B6 (cs) 2011-11-09
NZ512574A (en) 2004-03-26
ZA200105114B (en) 2002-11-21
WO2000039299A3 (fr) 2000-11-02
ATE394489T1 (de) 2008-05-15
KR101170203B1 (ko) 2012-07-31
AR029322A1 (es) 2003-06-25
CN101134775A (zh) 2008-03-05
WO2000039299A2 (fr) 2000-07-06
PL349777A1 (en) 2002-09-09
CN1654657A (zh) 2005-08-17

Similar Documents

Publication Publication Date Title
DK1141306T3 (da) Streptococcus-antigener
NO20026121D0 (no) Streptokokkantigener
NO20004161D0 (no) Gruppe B streptokokkantigener
DK1421956T3 (da) Polyol-IFN-beta-konjugater
DE69904211T2 (de) Polyalkoxylierte naphtopyrans
DE59911453D1 (de) Aktivkohlefilter
DE69812868T2 (de) Flanschreformierungsanlage
NO20006191D0 (no) Vaksine
FI980536A0 (fi) Monteringslinje
DE69905536T2 (de) Gyriconscheibe
DE69939653D1 (de) Erkstoff
DE69901852D1 (de) Perfluorodioxolen
IT1307252B1 (it) Cerniera lampo
ID28624A (id) Turunan 2-fenilpiran-4-on
NO20005599D0 (no) Vaksine
DE29806346U1 (de) Flugzeug
DE29820247U1 (de) Leuchtmittel
NO20005141D0 (no) Streptokokkpreparat
DE69917377D1 (de) Siphonanordnungen
FI980821A0 (fi) Nabb foer fordonsdaeck
DE29816091U1 (de) Flugzeug
DE29807387U1 (de) Schließe
DE29801992U1 (de) Halteorgan
DE29820409U1 (de) Jätharke
NO981958D0 (no) Posisjonsangiver